Your browser doesn't support javascript.
loading
Characteristics of chronic lymphocytic leukemia patients achieving 5+ years of remission after FC-based first-line treatment: Retrospective observations from the FILO group.
Guillermin, Yann; Herbaux, Charles; Subtil, Fabien; Aurran-Schleinitz, Thérèse; Cymbalista, Florence; Letestu, Remi; Leprêtre, Stéphane; Vaudaux, Sandrine; Laribi, Kamel; Leblond, Véronique; Defoi, Yasmina; Benchikh, Raouf; Salles, Gilles; Godmer, Pascal; Jardel, Henry; Vallais, Fréderic; Feugier, Pierre; Orsini, Frédérique; Pegourié, Brigitte; Lévy, Vincent; Michallet, Anne-Sophie.
Afiliação
  • Guillermin Y; Department of Clinical Hematology, Centre Léon Bérard, Lyon, France.
  • Herbaux C; Department of Clinical Hematology, Hospices Civils de Lyon, Lyon, France.
  • Subtil F; Department of Clinical Hematology, Hôpital Huriez, CHRU, Lille, France.
  • Aurran-Schleinitz T; Hospices Civils de Lyon, Service de Biostatistique, CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Lyon, France.
  • Cymbalista F; Department of Clinical Hematology, Institut Paoli-Calmettes, Marseille, France.
  • Letestu R; URC/CRC, Hôpital Avicenne, Assistance Publique-Hôpitaux De Paris, Bobigny, France.
  • Leprêtre S; URC/CRC, Hôpital Avicenne, Assistance Publique-Hôpitaux De Paris, Bobigny, France.
  • Vaudaux S; Department of Clinical Hematology, Centre de Lutte contre le Cancer de Haute-Normandie (CLCC) H. Becquerel, Rouen, France.
  • Laribi K; Department of Clinical Hematology, Centre de Lutte contre le Cancer de Haute-Normandie (CLCC) H. Becquerel, Rouen, France.
  • Leblond V; Department of Clinical Hematology, Centre Hospitalier Departmental, Le Mans, France.
  • Defoi Y; Department of Clinical Hematology, Paris 6 Pierre et Marie Curie, Paris, France.
  • Benchikh R; Department of Clinical Hematology, Paris 6 Pierre et Marie Curie, Paris, France.
  • Salles G; Department of Clinical Hematology, Paris 6 Pierre et Marie Curie, Paris, France.
  • Godmer P; Department of Clinical Hematology, Hospices Civils de Lyon, Lyon, France.
  • Jardel H; Department of Clinical Hematology, Hôpital Huriez, CHRU, Lille, France.
  • Vallais F; Hospices Civils de Lyon, Service de Biostatistique, CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Lyon, France.
  • Feugier P; Department of Clinical Hematology, Institut Paoli-Calmettes, Marseille, France.
  • Orsini F; URC/CRC, Hôpital Avicenne, Assistance Publique-Hôpitaux De Paris, Bobigny, France.
  • Pegourié B; Department of Clinical Hematology, Centre de Lutte contre le Cancer de Haute-Normandie (CLCC) H. Becquerel, Rouen, France.
  • Lévy V; Department of Clinical Hematology, Centre Hospitalier Departmental, Le Mans, France.
  • Michallet AS; Department of Clinical Hematology, Paris 6 Pierre et Marie Curie, Paris, France.
Am J Hematol ; 93(1): E24-E27, 2018 01.
Article em En | MEDLINE | ID: mdl-29055105
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França